Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
IO Biotech, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
3
| Kurma Partners (10% Owner) has filed a Form 3 on IO Biotech, Inc. |
| 08/15/2023 |
4
| Hunter Heidi (Director) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 64,238 options to buy
@ $1.83, valued at
$117.6k
|
|
| 08/15/2023 |
3
| Hunter Heidi (Director) has filed a Form 3 on IO Biotech, Inc. |
| 08/11/2023 |
4
| Elling Christian E (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 7,901,234 shares
@ $1.9, valued at
$15M
Granted 7,901,234 warrants
@ $2.47, valued at
$19.5M
|
|
| 08/11/2023 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 7,901,234 shares
@ $1.9, valued at
$15M
Granted 7,901,234 warrants
@ $2.47, valued at
$19.5M
|
|
| 08/11/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 2,469,135 shares
@ $2.025, valued at
$5M
Bought 2,469,135 warrants
@ $2.47, valued at
$6.1M
|
|
| 08/10/2023 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 3,157,894 shares
@ $1.9, valued at
$6M
Bought 3,157,894 warrants
@ $2.47, valued at
$7.8M
|
|
| 08/09/2023 |
4
| Zocca Mai-Britt (CEO) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 37,037 shares
@ $1.9, valued at
$70.4k
Granted 37,037 warrants
@ $2.47, valued at
$91.5k
|
|
| 08/09/2023 |
4
| Sullivan Amy (CFO) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 49,382 shares
@ $1.9, valued at
$93.8k
Granted 49,382 warrants
@ $2.47, valued at
$122k
|
|
| 08/09/2023 |
4
| Smith Devin Whittemore (General Counsel) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 4,938 shares
@ $1.9, valued at
$9.4k
Granted 4,938 warrants
@ $2.47, valued at
$12.2k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2023 |
4
| Al-Hajj Muhammad (Chief Scientific Officer) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 120,000 options to buy
@ $1.98, valued at
$237.6k
|
|
| 03/22/2023 |
4
| Zocca Mai-Britt (CEO) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.98, valued at
$990k
|
|
| 03/22/2023 |
4
| Sullivan Amy (CFO) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 55,000 options to buy
@ $1.98, valued at
$108.9k
|
|
| 03/22/2023 |
4
| Burkavage Brian (Chief Accounting Officer) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.98, valued at
$99k
|
|
| 03/22/2023 |
4
| Ehrnrooth Eva (Chief Medical Officer) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 120,000 options to buy
@ $1.98, valued at
$237.6k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Smith Devin Whittemore (General Counsel) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 150,000 options to buy
@ $2.6, valued at
$390k
|
|
| 01/13/2023 |
3
| Smith Devin Whittemore (General Counsel) has filed a Form 3 on IO Biotech, Inc. |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Elling Christian E (Director) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 23,885 options to buy
@ $4.85, valued at
$115.8k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/12/2021 |
4
| HBM Healthcare Investments (Cayman) Ltd. (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,365,545 shares
@ $0
Bought 325,000 shares
@ $14, valued at
$4.6M
Converted 188,168 preferred shares
@ $0 |
|
| 11/12/2021 |
4
| Malier Vanessa (Director) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 796,059 shares
@ $0
Converted 267,977 shares
@ $0
Bought 162,500 shares
@ $14, valued at
$2.3M
Bought 162,500 shares
@ $14, valued at
$2.3M
Converted 63,350 preferred shares
@ $0
Converted 21,325 preferred shares
@ $0 |
|
| 11/12/2021 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,365,545 shares
@ $0
Bought 650,000 shares
@ $14, valued at
$9.1M
Converted 188,168 preferred shares
@ $0 |
|
|
|
|